Another feature of pancreatic cancer is characterized by a highly immunosuppressive microenvironment that is built up by lacking intra-tumor effector T lymphocytes, existing mutant K-ras-driven oncogenic-prone inflammation, infiltrating suppressive immune cells and establishing the dense desmoplastic stromal reactions [16, 60, 61]. The gene discussed is KRAS; the disease is neoplasm.